Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.35 | N/A |
| PEG Ratio (TTM) | -0.34 | N/A |
| P/S Ratio (TTM) | 0.30 | N/A |
| P/B Ratio (TTM) | 1.67 | N/A |
| P/FCF Ratio (TTM) | 22.07 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.78 | N/A |
| Price to 5YR AVG FCF Ratio | 19.50 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.71% | N/A |
| ROE (TTM) | 19.76% | N/A |
| Net Profit Margin (TTM) | 2.27% | N/A |
| ROIC 5YR AVG | 9.77% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 18.08% | 105.01% | 56.34% |
| Revenue | -1.96% | 8.83% | 12.47% |
| Net Income | 34.79% | 109.77% | 59.33% |
| Cash Flow | 4,759.61% | 433.08% | 261.90% |
Health (30%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.16 | N/A |
| Quick Ratio (TTM) | 0.66 | N/A |
| D/E Ratio (TTM) | 1.76 | N/A |
| Interest Coverage (TTM) | 1.57 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.32 | N/A |
| LTL to 5YR AVG FCF | 11.40 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.05% | N/A |